GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
Oct 09, 2024
GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.
https://www.wsj.com/articles/gsk-reached-agreements-with-10-plaintiff-firms-over-zantac-litigation-7eb97208?mod=pls_whats_news_us_business_f
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service